New Vice President Marketing & Sales

New Vice President Marketing & Sales

Nils Sellbom has been appointed Vice President Marketing and Sales. Today Nils
is the Head of Sales Americas and President of Vitrolife's subsidiary in the
USA. Previously he was President of the company that Vitrolife acquired at the
beginning of 2006, Swemed. Jonas Falk, who today is responsible for Vitrolife's
sales in the Middle East, Asia and Oceania, has been appointed Head of Sales
Americas and will be based in the USA. “We are happy that Nils has taken on the
work of further developing the sales organization. Nils has long and solid
experience, amongst other things from several years within Astra Zeneca China as
Vice President Marketing and Sales, and has done a very good job in the USA
during the past year, where we have seen a very positive development of sales,”
say Vitrolife's President and CEO Magnus Nilsson. 

Vitrolife's sales director and Vice President Christer de Flon will leave the
company on May 1, 2007 after a total of just over 4 years at Vitrolife, to take
up the position of President of Blå Stjärnan. “Christer de Flon has done a
fantastic job for Vitrolife in building up our sales organization and we wish
him the best of luck in his new position”. 



Kungsbacka March 15, 2007

Magnus Nilsson
President and CEO














Queries should be addressed to: 
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.


________________________________________________________________________________
_________
Vitrolife is a global biotechnology/medical device Group that works with
developing, manufacturing and selling advanced products and systems for the
preparation, cultivation and storage of human cells, tissue and organs. The
company has business activities within three product areas: Fertility,
Transplantation and Stem Cell Cultivation. The Fertility product area works with
nutrient solutions (media) and advanced one-time instruments such as needles and
pipettes, for the treatment of human infertility. The Transplantation product
area works with solutions and systems to maintain tissue in optimal condition
outside the body for the required time while waiting for transplantation. The
Stem Cell Cultivation product area works with media and instruments to enable
the use and handling of stem cells for therapeutic purposes. 
     Vitrolife today has approximately 120 employees and the company's products
are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and
there are subsidiaries outside Gothenburg, Sweden and in Denver, USA. The
Vitrolife share is listed on the Stockholm Stock Exchange's Nordic Small Cap
list.
________________________________________________________________________________
_________
Vitrolife AB (publ), Faktorvägen 13, SE-434 37 Kungsbacka, Sweden. Corporate
identity number 556354-3452.
Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com.
Homepage: www.vitrolife.com.